A. Mar

A novel AMPK activator shows therapeutic potential in hepatocellular carcinoma by suppressing HIF1α‐mediated aerobic glycolysis

Meng-Hsuan Lee, Chih-Lung Lin, Jui-Wen Huang, 2022, Molecular oncology.

Abstract 1361: The decoy receptor interleukin-1 receptor type 2 acts as an angiogenic factor in human colorectal cancer

A. Mar, 2015 .

Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis*

Shung-Haur Yang, Te-Chang Lee, Jeng-Kai Jiang, 2015, The Journal of Biological Chemistry.

Blocking TNF-α inhibits angiogenesis and growth of IFIT2-depleted metastatic oral squamous cell carcinoma cells.

K. Lai, Zi-Xuan Hong, Chung-Ji Liu, 2016, Cancer letters.

Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis

Pei-Yi Chu, Kuen-Feng Chen, Chun-Yu Liu, 2016, Scientific Reports.

Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma

Chien-Jen Chen, Y. Pu, Te-Chang Lee, 2017, Oncotarget.

Blocking TNF-α inhibits angiogenesis and growth of IFIT2-depleted metastatic oral squamous cell carcinoma cells.

Zi-Xuan Hong, Chung-Ji Liu, Te-Chang Lee, 2016, Cancer letters.